By Colin Kellaher
Enovis has hired Damien McDonald to succeed Matt Trerotola as chief executive of the medical-technology company.
Enovis on Wednesday said McDonald, who most recently served as CEO of medical-device company LivaNova, takes the helm of the Wilimington, Del., company on May 12 and will also join the board.
Enovis in February said Trerotola, who has been CEO since 2015, was planning to retire.
The company on Wednesday said Trerotola, who is currently chairman, won't stand for re-election to the board at the annual shareholder meeting on May 21 and that Sharon Wienbar, who has served as lead independent director since May 2023, will become independent board chair.
Enovis said McDonald, 60 years old, will receive an annual base salary of $1 million and an annual bonus with a target of 125% of his base pay.
Write to Colin Kellaher at colin.kellaher@wsj.com
(END) Dow Jones Newswires
April 02, 2025 06:52 ET (10:52 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。